The canonical ZEB2 gene, recently recognized as a tumor suppressor [18, 21], is known to regulate the Epithelial–Mesenchymal Transition (EMT) program, a pathway that changes adherent epithelial cells into less adherent migratory cells, a process critical for oncogenic progression and metastasis of tumor cells [22]. The gene discussed is ZEB2; the disease is neoplasm.